Hsbc Holdings PLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Hsbc Holdings PLC

  • $168 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$17.63 - $21.74 $288,356 - $355,579
16,356 New
16,356 $322,000
Q4 2021

Feb 11, 2022
SELL
$10.39 - $15.15 $104,315 - $152,106
-10,040 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$11.39 - $16.23 $114,355 - $162,949
10,040 New
10,040 $115,000
Q4 2019

Feb 14, 2020
SELL
$5.24 - $12.96 $77,185 - $190,900
-14,730 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$8.15 - $15.88 $120,049 - $233,912
14,730 New
14,730 $125,000

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $751M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email